The overall survival obtained with these regimens is 70 to 80 % but there may be significant risks of secondary malignancies and cardiac problems due specifically to the radiotherapy component of treatment, which has prompted attempts to reduce these problems with dose-adjusted regimens[ 1 ].
1
—
—